• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges associated and approaches for successful translation of nanomedicines into commercial products.

作者信息

Agrahari Vivek, Hiremath Praveen

机构信息

Technical Development, Bayer U.S. LLC, Shawnee, KS 66210, USA.

Formulation Technology, Bayer Animal Health GmbH, Leverkusen 51368, Germany.

出版信息

Nanomedicine (Lond). 2017 Apr;12(8):819-823. doi: 10.2217/nnm-2017-0039. Epub 2017 Mar 24.

DOI:10.2217/nnm-2017-0039
PMID:28338401
Abstract
摘要

相似文献

1
Challenges associated and approaches for successful translation of nanomedicines into commercial products.纳米药物成功转化为商业产品所面临的挑战及方法。
Nanomedicine (Lond). 2017 Apr;12(8):819-823. doi: 10.2217/nnm-2017-0039. Epub 2017 Mar 24.
2
Nanomaterial Drug Products: Manufacturing and Analytical Perspectives.纳米材料药物产品：制造与分析视角
AAPS J. 2017 Jan;19(1):18-25. doi: 10.1208/s12248-016-0008-x. Epub 2016 Nov 7.
3
Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.现有的标准方法是否适用于纳米药物的评估：一些案例研究。
Nanomedicine (Lond). 2018 Mar 1;13(5):539-554. doi: 10.2217/nnm-2017-0338. Epub 2018 Jan 30.
4
Nanomedicines - Tiny particles and big challenges.纳米药物——微小颗粒与巨大挑战。
Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:23-43. doi: 10.1016/j.addr.2019.06.003. Epub 2019 Jun 19.
5
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities.将纳米药物转化为临床产品的促进因素：挑战与机遇。
Drug Discov Today. 2018 May;23(5):974-991. doi: 10.1016/j.drudis.2018.01.047. Epub 2018 Jan 31.
6
Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.用于药物递送的纳米颗粒：报告粒度参数时需要精确性。
Eur J Pharm Biopharm. 2008 May;69(1):1-9. doi: 10.1016/j.ejpb.2007.08.001. Epub 2007 Aug 7.
7
A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.纳米药物的当前科学与监管现状及未来挑战综述。
PDA J Pharm Sci Technol. 2011 Mar-Apr;65(2):177-95.
8
Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.纳米药物相关的监管问题：为下一代纳米药物奠定基础。
Nanomedicine (Lond). 2007 Apr;2(2):143-7. doi: 10.2217/17435889.2.2.143.
9
An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review.纳米结构药物传递系统的分析特性概述：迈向绿色和可持续的药物学：综述。
Anal Chim Acta. 2012 Sep 26;744:8-22. doi: 10.1016/j.aca.2012.07.010. Epub 2012 Jul 16.
10
Nanomedicines: The magic bullets reaching their target?纳米药物：直击病灶的“魔弹”？
Eur J Pharm Sci. 2019 Feb 1;128:73-80. doi: 10.1016/j.ejps.2018.11.019. Epub 2018 Nov 20.

引用本文的文献

1
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Anticancer Phytochemical Delivery: Advances, Challenges, and Future Prospects.用于抗癌植物化学物质递送的固体脂质纳米粒和纳米结构脂质载体：进展、挑战与未来展望
Pharmaceutics. 2025 Aug 21;17(8):1079. doi: 10.3390/pharmaceutics17081079.
2
Anti-Gastric Cancer Activity of Mixed-Region Iranian Propolis Nanoparticles: Potential Therapeutic Applications.伊朗混合区域蜂胶纳米颗粒的抗胃癌活性：潜在治疗应用
Curr Ther Res Clin Exp. 2025 Jul 16;103:100806. doi: 10.1016/j.curtheres.2025.100806. eCollection 2025.
3
Recent advances in the bench-to-bedside translation of cancer nanomedicines.
癌症纳米药物从实验室到临床应用转化的最新进展。
Acta Pharm Sin B. 2025 Jan;15(1):97-122. doi: 10.1016/j.apsb.2024.12.007. Epub 2024 Dec 14.
4
Current views and trends of nanomaterials as vectors for gene delivery since the 21st century: a bibliometric analysis.21世纪以来纳米材料作为基因传递载体的当前观点与趋势：一项文献计量分析
Nanomedicine (Lond). 2025 Mar;20(5):439-454. doi: 10.1080/17435889.2025.2457781. Epub 2025 Jan 29.
5
Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion.基于外泌体的药物递送系统用于治疗糖尿病及其并发症：当前观点
Extracell Vesicles Circ Nucl Acids. 2023 Sep 4;4(3):502-517. doi: 10.20517/evcna.2023.32. eCollection 2023.
6
Lipid Nanoparticles: An Effective Tool to Improve the Bioavailability of Nutraceuticals.脂质纳米粒：提高营养保健品生物利用度的有效工具。
Int J Mol Sci. 2023 Oct 30;24(21):15764. doi: 10.3390/ijms242115764.
7
Tumor-derived systems as novel biomedical tools-turning the enemy into an ally.肿瘤衍生系统作为新型生物医学工具——化敌为友。
Biomater Res. 2023 Nov 9;27(1):113. doi: 10.1186/s40824-023-00445-z.
8
Large-Scale Cultivation of Magnetotactic Bacteria and the Optimism for Sustainable and Cheap Approaches in Nanotechnology.大规模培养磁细菌及其在纳米技术中可持续和廉价方法的前景。
Mar Drugs. 2023 Jan 19;21(2):60. doi: 10.3390/md21020060.
9
Nanocarriers for ocular drug delivery: current status and translational opportunity.用于眼部药物递送的纳米载体：现状与转化机遇
RSC Adv. 2020 Jul 24;10(46):27835-27855. doi: 10.1039/d0ra04971a. eCollection 2020 Jul 21.
10
α-Acylamino-β-lactone -Acylethanolamine-hydrolyzing Acid Amidase Inhibitors Encapsulated in PLGA Nanoparticles: Improvement of the Physical Stability and Protection of Human Cells from Hydrogen Peroxide-Induced Oxidative Stress.包裹于聚乳酸-羟基乙酸共聚物纳米颗粒中的α-酰基氨基-β-内酯-酰基乙醇胺水解酸酰胺酶抑制剂：改善物理稳定性并保护人类细胞免受过氧化氢诱导的氧化应激
Antioxidants (Basel). 2022 Mar 31;11(4):686. doi: 10.3390/antiox11040686.